MySpondylitisTeam

Cosentyx (Secukinumab) is a prescription medication approved by the FDA to treat adults with active ankylosing spondylitis. It is an immunomodulator that works by inhibiting interleukin (IL)-17A, a chemical messenger involved in autoimmune attacks.

While individual experiences may vary, many people have reported positive Show Full Answer

Cosentyx (Secukinumab) is a prescription medication approved by the FDA to treat adults with active ankylosing spondylitis. It is an immunomodulator that works by inhibiting interleukin (IL)-17A, a chemical messenger involved in autoimmune attacks.

While individual experiences may vary, many people have reported positive results with Cosentyx. The time it takes to see improvement can differ from person to person. Typically, after the initial loading doses, Cosentyx is administered every four weeks by subcutaneous injection.

For more detailed personal experiences, you can visit the MySpondylitisTeam website and connect with others who have used Cosentyx.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Cosentyx (Secukinumab) for Spondylitis | MySpondylitisTeam

Taking Biologics: Dosing, Insurance Coverage, and When You Can Stop (VIDEO) | MySpondylitisTeam